Adenosine prevents K+-induced Ca2+ loading: Insight into cardioprotection during cardioplegia

Annals of Thoracic Surgery

Volumn 65, Issue 2, 1998, Pages 586-591

  Jovanović, Aleksandar ^a   Lopez, Jose R ^a   Alekseev, Alexey E ^a   Shen, Win K ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CALCIUM ION; CARDIOPLEGIC AGENT; POTASSIUM ION; PROTEIN KINASE C;

CALCIUM CELL LEVEL; CARDIOPLEGIA; DIASTOLE; ENZYME ACTIVATION; HEART ARREST; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HYPERKALEMIA; MEMBRANE DEPOLARIZATION; OPEN HEART SURGERY; PRIORITY JOURNAL; REVIEW;

ADENOSINE; CALCIUM; CARDIOPLEGIC SOLUTIONS; HEART ARREST, INDUCED; HUMANS; MYOCARDIUM; POTASSIUM; PROTECTIVE AGENTS; VENTRICULAR DYSFUNCTION;

EID: 0032004907     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)01240-X     Document Type: Review

References (52)

1. 1. Engelman RM, Levitsky S. A textbook for cardioplegia for difficult clinical problems. Mount Kisco, NY: Futura, 1992.
2. 2. Cyran SE, Philips J, Ditty S, Baylen BG, Cheung J, LaNou K. Developmental differences in cardiac myocyte calcium homeostasis after steady-state potassium depolarization: mechanisms and implications for cardioplegia. J Pediatr 1993;122:877-83.
3. 2+ waves: a laser confocal microscopy study. Am J Physiol 1996;270:H1384-9.
4. 4. Lopez JR, Jovanović A, Terzic A. Spontaneous calcium waves without contraction in cardiac myocytes. Biochem Biophys Res Commun 1995;214:781-7.
5. 2+-overload in reperfused ischemic myocardium. Annu Rev Physiol 1990;52:543-59.
6. 6. Kloner RA, Przykklenk K, Kay GL. Clinical evidence for stunned myocardium after coronary artery bypass surgery. J Card Surg 1994;9:397-402.
7. 7. McKenney PA, Apstein CS, Mendes LA, et al. Increased left ventricular diastolic chamber stiffness immediately after coronary artery bypass surgery. J Am Coll Cardiol 1994;24: 1189-94.
8. 2+ activation of contraction as a consequence of reperfusion injury induced cellular calcium overload in ferret hearts. J Clin Invest 1987;79:950-61.
9. 9. Steenbergen C, Murphy E, Watts JA, London RE. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 1990;66:135-46.
10. 10. Vinten-Johansen J, Nakanishi K, Zhao ZQ, McGee DS, Tan P. Acadesine improves surgical myocardial protection with blood cardioplegia in ischemically injured canine heart. Circulation 1993;88(Suppl 2):350-8.
11. 11. De Jong JW, Der Meer PV, Loon HV, Owen P, Opie LH. Adenosine as an adjunct to potassium cardioplegia: effect on function, energy metabolism, and electrophysiology. J Thorac Cardiovasc Surg 1990;100:445-54.
12. 12. Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J. Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 1992;86:986-94.
13. 13. Hudspeth DA, Nakanashi K, Vinten-Johansen J, et al. Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann Thorac Surg 1994;58: 1637-44.
14. 14. Gatell JA, Barner HB, Shevde K. Adenosine and myocardial protection. J Cardiothorac Vasc Anesth 1993;7:466-80.
15. 15. Lasley RD, Mentzer RM. The role of adenosine in extended myocardial preservation with the University of Wisconsin solution. J Thorac Cardiovasc Surg 1994;107:1356-63.
16. 16. Vinten-Johansen J, Zhao Z, Sayo H. Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy. Ann Thorac Surg 1995;60:852-7.
17. 17. Mullane K. The prototype adenosine regulating agent for reducing myocardial ischemic injury. Cardiovasc Res 1993; 27:43-7.
18. 18. Mangano DT, for the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Effects of acadesine on myocardial infarction, stroke and death following surgery. A meta-analysis of the 5 international randomized trials. JAMA 1996;277:325-32.
19. 19. Belardinelli L, Shryock JC, Song Y, Wang D, Srinivas M. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J 1995;9:359-65.
20. 20. Mubagwa K, Mullane K, Flameng W. Role of adenosine in the heart and circulation. Cardiovasc Res 1996;32:797-813.
21. 21. Shen WK, Kurachi Y. Mechanisms of adenosine-mediated actions on cellular and clinical cardiac electrophysiology. Mayo Clin Proc 1995;70:274-91.
22. +-induced membrane depolarization in ventricular cardiomyocytes: possible implication in hyperkalemic cardioplegia. J Mol Cell Cardiol 1996;28:1193-202.
23. 23. Cox MH, O S-J, Hebbar L, Mukherjee R, Crawford FA Jr, Spinale FG. Protective effects of adenosine on myocyte contractility during cardioplegic arrest. Ann Thorac Surg 1997;63:981-7.
24. 24. Jovanović A, Alekseev AE, Lopez JR, Shen WK, Terzic A. Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg 1997;63:153-61.
25. 25. Gomez LA, Alekseev AE, Aleksandrova LA, Brady PA, Terzic A. Use of the MTT assay in adult ventricular cardiomyocytes to assess viability: effects of adenosine and potassium on cellular survival. J Mol Cell Cardiol 1997;29:1255-66.
26. 26. Katayama O, Ledingham SJ, Amrani M, et al. Functional and metabolic effects of adenosine in cardioplegia: role of temperature and concentration. Ann Thorac Surg 1997;63: 449-54.
27. + channel opening drugs. Am J Physiol 1995;269:C525-45.
28. 28. Terzic A, Tung RT, Kurachi Y. Nucleotide regulation of ATP sensitive potassium channels. Cardiovasc Res 1994;28: 746-53.
29. + channels. Eur J Pharmacol 1995;286:R1-R2.
30. + channel. Biochem Pharmacol 1997; 54:219-25.
31. + channel of cardiac muscle and action potential shortening during metabolic stress. Cardiovasc Res 1994;28:760-1.
32. 32. Wilde AAM, Janse MJ. Electrophysiological effects of ATP-sensitive potassium channel modulation: implications for arrhythmogenesis. Cardiovasc Res 1994;28:16-24.
33. 33. Grover GJ. Protective effect of ATP sensitive potassium channel openers in models of myocardial ischaemia. Cardiovasc Res 1994;28:778-82.
34. 2+ loading in cardiomyocytes. Eur J Pharmacol 1996;308:343-9.
35. 35. Lopez JR, Jahangir R, Jahangir A, Shen WK, Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg 1996;112:820-31.
36. 36. Lawton JS, Hsia PW, Allen CT, Damiano RJ Jr. Myocardial protection in the acutely injured heart: hyperpolarizing versus depolarizing hypothermic cardioplegia. J Thorac Cardiovasc Surg 1997;113:567-75.
37. + channels by antagonizing the ATP-dependent gating. Neuron 1994;12:885-93.
38. 1-receptors. Circulation 1994;86:1310-6.
39. 1 receptor-mediated cardioprotection in stunned myocardium. Circulation 1993;88:235-44.
40. ATP channels. Am J Physiol 1996;271:H2710-6.
41. 2+ in adult rat cardiac myocytes. Circ Res 1990;66:143-5.
42. 42. Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischaemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994;26: 661-8.
43. 43. Baxter GF, Goma FM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol 1995;115: 222-4.
44. 44. Henry P, Demolombe S, Puceat M, Escande D. Adenosine stimulation activates delta protein kinase C in rat ventricular myocytes. Circ Res 1996;78:161-5.
45. 45. Sakamoto J, Miura T, Goto M, Iimura O. Limitation of myocardial infarct size by adenosine A(1) receptor activation is abolished by protein kinase C inhibitors in the rabbit. Cardiovasc Res 1995;29:682-8.
46. 46. Thornton JD, Liu GS, Olsson RA, Downey JM. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992;85:659-65.
47. 47. Booling SF, Childs KF, Ning XH. Adenosine's effect on myocardial functional recovery: substrate or signal? J Surg Res 1994;57:591-5.
48. 2+ concentration during and after metabolic inhibition. Cardiovasc Res 1990;24:605-8.
49. 2+ domain-dependent protective action of adenosine in cardiomyocytes. Eur J Pharmacol 1996;298:63-9.
50. 2+ loading [Letter]. Ann Thorac Surg 1997;64:588-9.
51. 51. Fremes SE, Levy SL, Christakis GT, et al. Phase 1 human trial of adenosine-potassium cardioplegia. Circulation 1996;94 (Suppl 2):370-5.
52. 52. Mentzer RM Jr, Rahko PS, Canver CC, et al. Adenosine reduces postbypass transfusion requirements in humans after heart surgery. Ann Surg 1996;224:523-9.